OXYCONTIN: payments to doctors
Payments that named OXYCONTIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.3M
- Providers
- 4
- Transactions
- 109
- Average per transaction
- $57,372
The per-transaction average — $57,372 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $1,563,381, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Purdue Pharma L.p. | $6,253,523 | 100.0% |